Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles

  • CABG Wins Again for Multivessel Disease

    In this contemporary trial of revascularization for multivessel disease, fractional flow reserve-guided percutaneous coronary intervention failed to meet noninferiority guidelines vs. coronary artery bypass grafting.

  • U.S. Chlamydia Rates Continue to Climb

    The chlamydia infection rate has been rising unabated. While rates of some STIs have fluctuated over the past 40 to 80 years, chlamydia rates have increased progressively since the first reporting data became available in 1984.
  • Herpes Vaccine Could Be Available by 2030

    Early efforts to produce a protein-based vaccine for herpes failed. But a new mRNA approach has outperformed the efficacy of the past vaccines in preclinical trials and is expected to be introduced in clinical trials in the second half of 2022, investigators say. This new approach for a prophylactic genital herpes vaccine showed great promise in early studies.

  • STI Rates Increasing, but Efficient Testing Can Help

    Incidence rates of many sexually transmitted infections (STIs) have increased in the years leading up to the COVID-19 pandemic. There is evidence that STIs have continued to rise during the pandemic, according to the results of a new study.
  • Accessing Hormonal Contraception by Pharmacy Prescriptions

    A stopgap step to increasing access to hormonal birth control is to expand prescribing authority to pharmacists. Compared to other clinical settings, pharmacies can be easier for people to access, given their wide distribution across the country and their extended hours of operation.
  • Researchers Highlight Isolation, Stigma of Abortion Providers in the South

    Abortion providers in the South face many challenges, including being outed online, fired from hospitals, and ostracized in professional and social circles, according to the results of a recent study.
  • Disrupted Contraceptive Care Hurt Disadvantaged Patients the Most

    The COVID-19 pandemic affected most women seeking contraceptive care — but those who already are disadvantaged by structural inequities were hit the hardest. The problem worsened as the pandemic continued. The pandemic made reproductive health access disparities worse, creating economic hardship for many women and disproportionately affecting Black, indigenous, and people of color. Recently, researchers found that people were less happy with their ability to access contraceptive care in January 2021 than in July 2020.
  • A Tale of Two Times: Contraceptive Care in the COVID-19 Pandemic

    Patients faced difficulties accessing contraceptive care in April 2020 and December 2020, but the steepest drop occurred during the COVID-19 shutdown in April 2020, according to researchers.
  • New Research Highlights Effect of COVID-19 on Contraceptive Care

    The COVID-19 pandemic caused disruptions and barriers to contraceptive care in its first year. Reproductive health providers have navigated conflicting and confusing messages about vaccine mandates.
  • Racism Reported by Nurses, Physicians

    Are nurses and physicians of color at your facility at risk of occupational racism? Employee health professionals should be aware of two recent reports that cited racial incidents, which negatively affected productivity and emotional wellness.